Introduction
Depression is one of the most prevalent behavioral and psychological symptoms in dementia [1] [2] [3] [4] . It may be the first symptom of dementia [5, 6] , but it may also be present at any stage of the disorder [7, 8] . It is presumed that about 50% of the patients with dementia will suffer from depression during the course of the disorder, with an equal distribution between major and minor depressive disorder [3, 5, 7, 9] . Depression is also common in patients with mild cognitive impairment (MCI), with reported prevalence rates varying as much as 3-63.3% [10] . The persistence rate of depression among patients with dementia is high and varies from 33 to 58% in different studies with follow-up times between 1 and 2 years [11] [12] [13] [14] . The different rates may reflect variations in the groups of patients being examined and differences in the diagnostic tools being used. In most studies, a cutoff point on a depression scale is used to define depression. Diagnoses are seldom made, and this could be another explanation for the different persistence rates.
Depression in dementia may cause serious problems for the patients and their caregivers. It may lead to reduced quality of life, disability in the activities of daily living [3] , an increased caregiver burden, increased referrals to nursing homes, and higher morbidity and mortality rates [15] [16] [17] . Therefore, efforts should be made to detect the disorder in this patient group.
Even though depression in dementia is a common condition, it is often underdiagnosed and undertreated according to Snowdon et al. [18] and Watson et al. [19] . The reason for this could be that the symptoms are not always pronounced, and many symptoms of depression and dementia overlap [7] . A psychiatric assessment of every patient referred to a memory clinic would be the best way to reveal psychiatric symptoms, but this is seldom possible due to limitations of time and resources. Evaluation scales have been shown to be useful as screening tools for depression, but may also determine the severity of depressive symptoms and quantify changes after specific treatment [16] . Thus, it may be practical to use standardized tools for assessment of and screening for depressive symptoms [20] .
Over the last two decades there has been a change in the group of patients referred to the memory clinics. The patients are now younger and less affected by dementia than what used to be the case. In many memory clinics in the Western world, the majority of the patients have either subjective memory complaints or symptoms qualifying for the diagnosis of MCI, while only about half of the patients have dementia [21] . A variety of diagnostic tools are in use to assess depressive symptoms in memory clinics. The most commonly used instrument among patients suffering from dementia in Norway is the Cornell Scale for Depression in Dementia (CSDD) [22] . In patients who are assumed not to be suffering from dementia, the most commonly used scale is the MontgomeryAasberg Depression Rating Scale (MADRS) [23] . This is recommended by the Norwegian Directorate of Health in the Norwegian guidelines for assessment of dementia [24] .
The CSDD has been validated in different clinical settings among cognitively impaired patients [25, 26] , and it is presumed to be suitable for both patients with and without dementia [22, 27] . To our knowledge, the MADRS has not been comprehensively validated in cognitively impaired patients. Two studies have compared the scales on the same group of patients. Müller-Thomsen et al. [28] used four different scales independently in a memory clinic and found that the CSDD and the MADRS had the highest correlation, but this study did not validate the scales against a clinical diagnosis of depression. There is one study comparing the validity of the two scales. This was carried out among younger patients with Alzheimer's disease (AD) living in an institution. Based on the same interview, both scales were scored by one caregiver, meaning that the two scales were not assessed independently [29] . Usually, the MADRS is scored after an interview with the patient, but in the study of Leontjevas et al. [29] the scoring was based on information obtained by proxy.
We have previously examined the validity of the CSDD in a nursing home population, and found it to be a fairly valid screening instrument in Norwegian institutions [30] . The aim of this study was to compare the validity of two different depression scales using two different sources of information in a heterogeneous outpatient population visiting a memory clinic for assessment of suspected dementia. The depression scales employed were the CSDD, based on information from a caregiver, and the MADRS based on an interview with the patients. Additionally, we compared the results between patients with and without dementia.
Methods

Design
To design the study, we used the criteria of Sackett et al. [31] for 'critical appraisal' regarding diagnostic tests. According to Sackett et al. [31] , a test is valid if the test is compared independently and 'blind' with a reference standard of diagnosis which is used regardless of the test result. The test has to be evaluated among the same type of patients in whom it is normally used. Further, it is important to know if the test has the ability to correctly distinguish patients who do or do not have a disease.
Subjects
We included 125 patients (98 patients with the MADRS and 121 patients with the CSDD) from two memory clinics between October 2008 and July 2010. Of them, 97 were recruited in an unselected manner at their first visit to the memory clinic at Oslo University Hospital, Ullevål, on workdays when a psychiatrist was present. The remaining 28 patients were recruited from the memory clinic at Innlandet Hospital Trust (SI). Of them, 20 subjects were included when they came for a follow-up appointment at the memory clinic. These patients were interviewed by a psychiatrist within 7 days. The only exclusion criterion was inability to communicate in Norwegian. The two groups did not differ regarding any of the variables presented in table 1 .
Diagnostic Procedures Dementia Diagnoses
The patients were examined by a physician in a standardized and comprehensive manner according to a protocol used for research at the two memory clinics. Both patients and caregivers were interviewed about symptoms of dementia. The patients went through a neuropsychological test session, including the MiniMental State Examination (MMSE) and the Clock Drawing Test (using the Shulman's scoring instructions from 0 to 5 [32] ) among many others (results from these two tests will be reported); a physical examination was performed, and blood samples were collected. The degree of dementia was assessed by the Clinical Dementia Rating Scale (CDR). All patients had an MRI scan to measure the medial temporal lobe. Some of the patients also underwent a single-photon emission computed tomography examination and a spinal fluid examination for measurement of a-beta and tau protein. Dementia diagnoses were made using the International Classification of Diseases-10 (ICD-10) for clinical research. MCI was diagnosed using the Winblad criteria [33] . The term subjective cognitive impairment (SCI) was used in cases that did not fulfill the criteria for dementia or MCI.
Depression Diagnoses Three geriatric psychiatrists who were not involved in the dementia assessment took part in the study to diagnose whether depression was present. They had access to all available information in the records except the information from the MADRS and the CSDD ratings (blinded to the results for the scales). They interviewed the patients and used a template with a list of all the symptoms of depression with regard to the ICD-10 (F32 mild, moderate or severe depression) and to the major depression criteria of the DSM-IV in the interview session. At Oslo University Hospital, the interview took place the same day as the data for the MADRS interview and the CSDD were collected, whereas the psychiatric interview at Innlandet Hospital took place within a week after the patients had been assessed with the two scales. One of the psychiatrists interviewed 68% of the patients. The psychiatrists discussed the diagnostic procedure and the diagnoses with each other during the study to ensure the quality of the diagnosis, but we did not perform a reliability study. Diagnosis of depression was made using the ICD-10 criteria for research and the DSM-IV criteria. These were considered the 'reference standards' in the study. Both criteria were applied because we expected the prevalence of depression to be much higher with the ICD-10 criteria, as these criteria include patients with depression of a milder degree than the DSM-IV criteria of major depression. In this way, comparison was possible.
The Scales Depressive symptoms during the last month were evaluated using the CSDD and the MADRS in two different interviews with two different informants, but on the same day. The CSDD is an observation-based instrument used to assess patients with and without dementia. It is designed for use in institutions, but most previous studies have been performed among outpatients. It is a 19-item instrument based on an interview with a caregiver or member of staff in a nursing home. Each item can be scored between 0 ('not present' or 'not possible to evaluate') and 2 ('often present'). The minimum score is 0 and the maximum is 38. A higher score indicates depression [22] . In the present study, a trained nurse at the memory clinic interviewed one or more caregivers (if present) and scored the 19 items in accordance with the caregivers' answers after ensuring that no questions could have been misunderstood. The nurse had no knowledge of the results of the MADRS interview or the psychiatrist's clinical depression diagnosis. The MADRS is normally based on an interview with the patient, and it consists of 10 items that can be scored between 0 and 6, giving a minimum score of 0 and a maximum score of 60. A higher score indicates depression [23] . Normally the patients are interviewed, which was the way we applied the scale. A trained physician carried out the interviews without knowledge of the results of the CSDD assessments or the psychiatrists' diagnoses.
We also assessed functional status (the activities of daily living) and used the Lawton Instrumental Activities of Daily Living scale. The scale consists of 8 items, and each item can be scored from 1 to 5, giving a minimum score of 8 and maximum score of 31. A higher score indicates functional impairment [34] .
Statistics
The statistics were performed using SPSS, version 16. Descriptive analyses were performed. Receiver operation characteristics (ROC analyses) were carried out to calculate the area under the curve (AUC). Accuracy, sensitivity, specificity and likelihood ratios for positive and negative tests for various cutoff points were calculated. Sensitivity is the probability of having a positive test if you have the disorder. Specificity is the probability of having a negative test if you do not have the disorder. Knowing a test's sen- 
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Results
Characteristics of Patients
Of the 125 patients in this study, 64 (51.2%) were men and 61 (48.8%) were women. The mean age was 67.4 years (SD: 9.2 years) with a mean age for men and women of 68.2 (SD: 8.8) and 66.5 years (SD: 9.4), respectively. The majority were married (85.6%). On average, they had 13.5 years of education. The mean Lawton Instrumental Activities of Daily Living score was 11.4 (SD: 5.1). The caregivers were mostly spouses (71.3%), or children of the patients (14.8%).
Dementia and MCI
Of the whole group, 29 (23%) had SCI, 41 (33%) had MCI, 27 (21%) had AD, and 28 (22.4%) had other types of dementia (vascular dementia, VaD, mixed AD/VaD, frontotemporal dementia, Parkinson's disease/Lewy body dementia, or unspecified). Of the whole group, 15.2% had a CDR score of 0, 45.6% a CDR score of 0.5, 31.2% of 1, and 8% a CDR score of 2. The mean score of MMSE was 25.5 (SD: 4.6), and 68% were capable of drawing a clock correctly (mean score 3.9 out of 5 points possible).
Depression
The CSDD was applied to 121 patients, and the mean score was 6.8 (SD: 4.9). The MADRS was applied to 98 patients, and the mean score was 8.5 (SD: 6.8). Both scales were used with 94 patients, and the mean scores of the two tests did not differ between these and the 121 and 98, respectively. The correlation (Spearman rho) between the two scales was 0.43 for the whole group, 0.48 for the patients with dementia, and 0.44 for those without dementia, respectively.
Of all 125 patients, 48 (38.4%) had a history of depression, and 31 (25%) used antidepressants at the time of assessment.
Assessment by the psychiatrists revealed that 51 patients (40.8%) had depression according to the criteria of ICD-10, most of them a depression of mild degree (33 of the depressed), and 34 (27.2%) had a major depressive disorder according to the DSM-IV criteria. All patients who met the criteria for a major depression were depressed according to the ICD-10 criteria as well.
Validity of the Scales
In the further analysis, the patients were dichotomized into two groups; 55 with dementia and 70 without dementia (SCI = 29, MCI = 41) according to their clinical diagnoses. Differences between the two groups are shown in table 1 .
ROC analyses were performed for the whole sample, for the groups with and without dementia for both scales, separately. We made separate analyses using the ICD-10 criteria and for the DSM-IV criteria ( fig. 1-4 ) . The differences expressed as the AUC for the two scales were small between the different groups.
For the evaluation of CSDD, the AUC was 0.73 (0.05; 0.63-0.82) using the ICD-10 criteria and 0.68 (0.06; 0.57-0.79) using the DSM-IV criteria for the whole group.
Using the ICD-10 criteria by evaluating the MADRS the AUC was 0.88 (0.04; 0.81-0.95) for the whole group. When we used the DSM-IV criteria, AUC fell to 0.84 (0.04; 0.76-0.92).
For details, see tables 2 and 3 . Cutoff points, giving the highest values of accuracy, sensitivity and specificity, are shown.
Discussion
In this study, we found a high prevalence of depression. About 41% of the patients satisfied the ICD-10 criteria for depression, mostly to a mild degree. Using the ICD-10 criteria as the reference standard, the MADRS had a numerical higher AUC compared to the CSDD in every group of patients. There was no difference in the AUC of the MADRS between patients with or without dementia, 0.85 (SE: 0.06; 95% CI: 0.74-0.97) and 0.88 (SE: 0.05; 95% CI: 0.78-0.98), respectively. The CSDD had an AUC of 0.74 (95% CI: 0.6-0.88) and 0.73 (95% CI: 0.61-0.85) in the group with and without dementia, respectively. Using the DSM-IV criteria, the results were a bit poorer, but the differences were small.
The cutoff point with best sensitivity and specificity for the CSDD was 5/6, and for the MADRS the best cutoff point was 6/7, independent of which diagnostic criteria were being used.
To our knowledge, there has been only one validation study evaluating both the MADRS and the CSDD in the same patient sample. Leontjevas did a validation study among nursing home patients using the Provisional Diagnostic Criteria for Depression in Alzheimer Disease as 'the gold standard'. The MADRS and the CSDD were filled out based on one single structured interview with the staff in the nursing homes, which means that the results of the two assessments were not 'blinded' for each other. Not surprisingly, they found a strong correlation between the two scales. We did not identify a strong correlation between the scales, and this was probably due to two different sources being used filling in the two scales.
In the study by Leontjevas, the ROC curves for the scales were also good, with an AUC of 0.87 for the MADRS and 0.76 for the CSDD. The highest sensitivity (0.75) and specificity (0.84) were achieved using a cutoff point of 19/20 for the MADRS. For the CSDD, the best cutoff point was 5/6, which gave a sensitivity of 0.83 and a specificity of 0.57. Leontjevas did suggest that the reasons for this result may be that the MADRS does not have questions about somatic symptoms, and the questions in the MADRS allowed more alternatives for the reply [29] . Our best cutoff point on the MADRS was substantially lower than the one of Leontjevas. The reason could be that we interviewed the patients, not the caregivers. We know from previous studies that patients with cognitive impairment often underreport symptoms of depression, whereas caregivers have a tendency to overreport [20] . Another explanation is the disparity in patient samples being studied. The use of different criteria for a depressive disorder can hardly be the explanation because by using the Provisional Diagnostic Criteria for Depression in Alz heimer Disease more patients will usually be defined as depressed than by using the ICD-10 or the DSM-IV criteria [30, 35] . The MADRS has not been validated in further studies including cognitively impaired patients, so we cannot compare our best cutoff point with other studies. The CSDD has been evaluated in different clinical settings, and it has been compared with other scales as, for instance, the Geriatric Depression Scale. Some studies have shown it to be valid in patients both with and without dementia [25, 36] , while others have found it incapable of differentiating between depressed and not depressed patients [37] . The cutoff points with the best sensitivity and specificity differ, and probably depend on cultural differences, patient populations and different study designs. We have validated the CSDD in a nursing home population and found different cutoff points (between 6/7 and 10/11), depending on which diagnostic criteria we used [30] . In the original validation study by Alexopoulos et al. [22] , the CSDD was compared with a psychiatric diagnosis using the Research Diagnostic Criteria, and no cutoff point was made. The mean score of 8 in the group of patients with minor depression in that study has been used as a cutoff point. Kørner et al. [25] reported a very high sensitivity (0.93) and specificity (0.97) with a cutoff point of 6 in a group of outpatients including patients both with and without dementia, and the AUC was 0.98. In this study, spouses of the patients were used as controls, which according to Sackett's definition, is not a valid contrast group [31] . Maixner et al. [36] found an AUC for the CSDD of 0.9 with a sensitivity of 0.72 and a specificity of 0.9 using a cutoff point of 8. In this study, the psychiatric diagnosis was not made 'blind' of the result of the CSDD. Watson et al. [37] used a modified version of the CSDD in a group of residential care patients and achieved a much lower AUC of 0.66 with a sensitivity of 0.47 and specificity of 0.65 at a cutoff point of 8. In this study, they used information from professional caregivers (nursing assistants) who had been trained (for 30 min) to use the scales. Teresi et al. [38] found a relatively low recognition rate of depression when the CSDD and other screening tools for depression were administered by the staff in nursing homes compared with the assessment of a psychiatrist. This illustrates the importance of the staff being trained to use the CSDD in a proper manner.
It is difficult to compare the results of the present study with those of Leontjevas et al. [29] . We used a 'blinded design' and examined depressive symptoms with the CSDD in an interview with a caregiver and the MADRS in an interview with the patients. To our knowledge, this is the first study using such a design in a memory clinic population. The explanation of the MADRS having a higher AUC than the CSDD could be put down to several causes. Firstly, it might be that the patients coming to a memory clinic have insight into their own situation and can give reliable information. Beattie et al. [39] showed that many of the patients are capable of expressing their feelings and emotions and have insight at least to some degree into their impairments. In our study, most of the persons with dementia had a dementia of mild degree, which could support their explanation. In the late stage of dementia, the MADRS would probably not be usable. A further explanation could be that both the MADRS and the psychiatrists' diagnosis were based on an interview with the patients, not the caregiver. Therefore, the result may be biased.
The study has some limitations. It would have been better if more than one psychiatrist had examined the patients, but for practical reasons this was not possible. The psychiatrist did however consult another psychiatrist when in doubt. It would also have been an advantage for the psychiatrist to have interviewed a caregiver in addition to the patient, a caregiver that had not been interviewed by a nurse using the CDSS.
To the best of our knowledge, this is the first study comparing the CSDD with the MADRS, both blinded for a psychiatric assessment, in a memory clinic population. We used the criteria of Sackett et al. [31] for 'critical appraisal' regarding diagnostic tests. Most of the patients were recruited using no selection criteria, and they were assessed in a comprehensive manner.
